Making sense of oesophageal contents

Gut

Volumn 57, Issue 4, 2008, Pages 435-438

  Fox, Mark ^a   Schwizer, Werner ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; ENDOSCOPY; ESOPHAGUS; ESOPHAGUS MOTILITY; GASTRIC PH MONITORING; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LOWER ESOPHAGUS SPHINCTER; NOTE; PATIENT CARE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH CONTENT; STOMACH FUNDOPLICATION; TREATMENT OUTCOME; AMBULATORY MONITORING; CHEMISTRY; METABOLISM; METHODOLOGY; PH; STOMACH JUICE;

ESOPHAGUS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL CONTENTS; HUMANS; HYDROGEN-ION CONCENTRATION; MONITORING, AMBULATORY;

EID: 41149153772     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.137638     Document Type: Note

References (45)

1. Fox M, Forgacs I. Gastro-oesophageal reflux disease. BMJ 2006;332:88-93.
2. Trudgill NJ, Riley SA. Transient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers. Am J Gastroenterol 2001;96:2569-74.
3. Pandolfino JE, Shi G, Curry J, et al. Esophagogastric junction distensibility: a factor contributing to sphincter incompetence. Am J Physiol Gastrointest Liver Physiol 2002;282:G1052-8.
4. Bredenoord AJ, Weusten BL, Timmer R, et al. Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux. Gastroenterology 2006;130:334-40.
5. Sifrim D. Relevance of volume and proximal extent of reflux in gastro-oesophageal reflux disease. Gut 2005;54:175-8.
6. Emerenziani S, Zhang X, Blondeau K, et al. Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux. Am J Gastroenterol 2005;100:1251-6.
7. Cadiot G, Bruhat A, Rigaud D, et al. Multivariate analysis of pathophysiological factors in reflux oesophagitis. Gut 1997;40:167-74.
8. Jones MP, Sloan SS, Jovanovic B, et al. Impaired egress rather than increased access: an important independent predictor of erosive oesophagitis. Neurogastroenterol Motil 2002;14:625-31.
9. Sonnenberg A, El-Serag HB. Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med 1999;72:81-92.
10. Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 2004;126:660-4.
11. Lee JD, Anggiansah A, Anggiansah R, et al. The effects of age on the gastro-esophageal junction, esophageal motility and reflux disease. Clin Gastroenterol Hepatol 2007;5:1392-8.
12. Fox M, Barr C, Nolan S, et al. The effects of dietary fat and calorie density on esophageal acid exposure and reflux symptoms. Clin Gastroenterol Hepatol 2007;5:439-44.
13. Bredenoord AJ, Weusten BL, Curvers WL, et al. Determinants of perception of heartburn and regurgitation. Gut 2006;55:313-8.
14. Emerenziani S, Sifrim D, Habib F, et al. Presence of gas in the refluxate enhances reflux perception in nonerosive patients with physiological acid exposure of the oesophagus. Gut 2008;57:443-7.
15. Fass R, Ofman JJ. Gastroesophageal reflux disease - should we adopt a new conceptual framework? Am J Gastroenterol 2002;97:1901- 9.
16. Trimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995;37:7-12.
17. Byrne PJ, Mulligan ED, O'Riordan J, et al. Impaired visceral sensitivity to acid reflux in patients with Barrett's esophagus. The role of esophageal motility. Dis Esophagus 2003;16:199-203.
18. Bradley LA, Richter JE, Pulliam TJ, et al. The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol 1993;88:11-19.
19. Hobson AR, Furlong PL, Sarkar S, et al. Neurophysiologic assessment of esophageal sensory processing in noncardiac chest pain. Gastroenterology 2006;130:80-8.
20. Labenz J, Nocon M, Lind T, et al. Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Am J Gastroenterol 2006;101:2457-62.
21. Johnson LF, Demeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974;62:325-32.
22. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80.
23. Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003;125:1670-7.
24. Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997;32:974-9.
25. Dean BB, Gano AD Jr, Knight K, et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004;2:656-64.
26. Bodger K, Trudgill N. Guidelines for oesophageal manometry and pH monitoring. BSG Guidelines, 2006.www.bsg.org.uk/pdf_word_docs/oesp_man.pdf (Accessed on 19 December 2007)
27. Nguyen HN, Silny J, Albers D, et al. Dynamics of esophageal bolus transport in healthy subjects studied using multiple intraluminal impedancometry. Am J Physiol 1997;273(4 Pt 1):G958-64.
28. Vela MF, Camacho-Lobato L, Srinivasan R, et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001;120:1599-606.
29. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006;55:1398-402.
30. Sifrim D, Dupont L, Blondeau K, et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut 2005;54:449-54.
31. Mainie I, Tutuian R, Agrawal A, et al. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006;93:1483-7.
32. Bredenoord AJ, Weusten BL, Smout AJ. Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut 2005;54:1810-7.
33. Fletcher J, Wirz A, Young J, et al. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001;121:775-83.
34. Richter JE, Bradley LA, DeMeester TR, et al. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992;37:849-56.
35. Pandolfino JE, Ghosh S, Zhang Q, et al. Slimline vs. glass pH electrodes: what degree of accuracy should we expect? Aliment Pharmacol Ther 2006;23:331-40.
36. Geus WP, Smout AJ, Kooiman JC, et al. Glass and antimony electrodes for long-term pH monitoring: a dynamic in vitro comparison. Eur J Gastroenterol Hepatol 1995;7:29-35.
37. Vandenplas Y, Helven R, Goyvaerts H. Comparative study of glass and antimony electrodes for continuous oesophageal pH monitoring. Gut 1991;32:708-12.
38. Sjoberg F, Gustafsson U, Tibbling L. Alkaline oesophageal reflux - an artefact due to oxygen corrosion of antimony pH electrodes. Scand J Gastroenterol 1992;27:1084-8.
39. Srinivasan R, Vela MF, Katz PO, et al. Esophageal function testing using multichannel intraluminal impedance. Am J Physiol Gastrointest Liver Physiol 2001;280:G457-62.
40. Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004;53:1024-31.
41. Fox M, Canavan R, Anggiansah A, et al. Increasing reflux study duration progressively improves diagnostic reproducibility and clinical impact; a prospective study with 96-hr wireless pH recordings. Gut 2007;132(suppl III):A75.
42. Fullard M, Kang JY, Neild P, et al. Systematic review: does gastro-oesophageal reflux disease progress? Aliment Pharmacol Ther 2006;24:33-45.
43. North of England Dyspepsia Guideline Development Group. Dyspepsia: managing dyspepsia in adults in primary care. National Institute of Clinical Excellence, London; 2004.www.nice.org.uk/CG017NICEguideline (Accessed on 19 December 2007)
44. Dickson EJ, Stuart RC. Genetics of response to proton pump inhibitor therapy: clinical implications. Am J Pharmacogenomics 2003;3:303-15.
45. Prakash C, Clouse RE. Wireless pH monitoring in patients with non-cardiac chest pain. Am J Gastroenterol 2006;101:446-52.